Manufacturer: Cipla, India
Pharmaceutical name: Lamivudine, Zidovudine, Nevirapine
Pack: 30 pills (150 mg / 300 mg / 200 mg)
```html
Duovir N is classified as an anti-HIV medication known as Nucleoside Reverse Transcriptase Inhibitors (NRTIs). Its active components, Lamivudine and Zidovudine (along with the additional ingredient Nevirapine), work to impede the replication of HIV in the body. These drugs are administered together to manage HIV infection, which can lead to AIDS.
Administer Duovir N precisely as prescribed by your healthcare provider. Each dose should be taken with a full glass of water. It can be consumed either with food or on an empty stomach. Typically, Duovir N is taken twice daily. Adhere to your doctor's guidance.
Side effects may include difficulty breathing, throat constriction, lip, tongue, or facial swelling, hives, muscle discomfort or weakness, nerve damage, numbness, tingling, mild nausea, vomiting, diarrhea, reduced appetite, headaches, dizziness, insomnia, and changes in body fat distribution.
Critical blood disorders such as decreased levels of red and/or white blood cells have been associated with Duovir N usage. If you experience unusual tiredness, pale skin, a sore throat, fever, or chills, contact your physician right away as these could indicate blood-related issues. Reports of lactic acidosis and severe liver complications, including fatal situations, have also been noted with Duovir N, whether alone or in combination.
It is advisable to avoid alcohol while using Duovir N, as it may heighten the risk of pancreatic and/or liver damage. Follow your doctor's advice regarding high-risk behaviors such as unprotected sex and sharing needles. It is important to note that Duovir N does not cure HIV or AIDS, and the virus can still be transmitted to others during treatment.
```